(3R,4R)-3,4-Dimethyl-4-(3-hydroxyphenyl)piperidine, 97.0%, 250mg

H-Lys(Boc)-OtBu HCl, 95.0%, 500g

Methyl 4-(bromomethyl)-3-methoxybenzoate, 98.0%, 10g

(E)-4,4,5,5-Tetramethyl-2-(2-methylstyryl)-1,3,2-dioxaborolane, 95+%, 250mg

2,2'-Bipyridine-6,6'-dicarboxylic Acid>98.0%(GC)(T)5g

Ethyl N-Phenylformimidate>98.0%(GC)25g

(R)-Methyl 2-(((benzyloxy)carbonyl)amino)-3-hydroxypropanoate, 95.0%, 500g

(2R,5R)-1-[2-(1,3-Dioxolan-2-yl)phenyl]-2,5-dimethylphospholane, 97%, 5g

Bolsas de eliminación SEKUROKA® PP, 50 ?m, 600 x 800 mm, 500 unidades

(2S,4R)-1-(tert-Butoxycarbonyl)-4-hydroxypiperidine-2-carboxylic acid, 95.0%, 1g

Aparato ultrasónico SONOREX DIGITEC, sin calefacción, 1,8 l, DT 52 1 pieza

TASIMELTEON, 95%, 25mg

1,7-Dibromo-3,4,9,10-perylenetetracarboxylic Dianhydride>98.0%(HPLC)5g